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Although transcriptional and posttranscriptional events are de-
tected in RNA-Seq data from second-generation sequencing, full-
length mRNA isoforms are not captured. On the other hand, third-
generation sequencing, which yields much longer reads, has
current limitations of lower raw accuracy and throughput. Here,
we combine second-generation sequencing and third-generation
sequencing with a custom-designed method for isoform identiﬁ-
cation and quantiﬁcation to generate a high-conﬁdence isoform
dataset for human embryonic stem cells (hESCs). We report 8,084
RefSeq-annotated isoforms detected as full-length and an addi-
tional 5,459 isoforms predicted through statistical inference. Over
one-third of these are novel isoforms, including 273 RNAs from
gene loci that have not previously been identiﬁed. Further char-
acterization of the novel loci indicates that a subset is expressed in
pluripotent cells but not in diverse fetal and adult tissues; more-
over, their reduced expression perturbs the network of pluripo-
tency-associated genes. Results suggest that gene identiﬁcation,
even in well-characterized human cell lines and tissues, is likely far
from complete.
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In the 5 y since the introduction of RNA-Seq (1, 2), there havebeen remarkable advances in our ability to analyze the tran-
scriptome. During this period, additional methods based on next-
generation sequencing (NGS) have been developed for the study
of many different aspects of RNA biology. These include
methods to study RNA species that are ribosome bound (3),
nuclear (4), implicated in RNA editing (5), functional noncoding
RNAs (6), in protein–RNA binding sites (7), and interacting in
microRNA–mRNA complexes (8). Concurrently, the increase in
NGS throughput and the development of multiplex sequencing
protocols have made RNA-Seq analysis as cost-effective as gene
expression microarrays.
Despite these advances, we are still far from achieving the
original goals of RNA-Seq analysis, namely the de novo discov-
ery of genes, the assembly of gene isoforms, and the accurate
estimation of transcript abundance at the gene or the isoform
level. Current RNA-Seq experiments are based on second-gen-
eration sequencing (SGS) instruments capable of generating
a large number of short reads. From these reads, one obtains two
types of information: (i) frequency of reads aligned to a contig-
uous genomic segment (exonic reads) and (ii) frequency of reads
aligned to two contiguous segments of the genome with a single
gap of from 60 bp to 400 kbp in size (junction reads) (9–11). If
the set of possible isoforms is assumed known (i.e., the gene is
well annotated), then it is possible to infer isoform-speciﬁc ex-
pression from exonic reads and junction reads based on simple
statistical models such as the Poisson deconvolution model of
Jiang and Wong (12). On the other hand, if the set of isoforms is
not known or only partially known, then currently there is great
difﬁculty in isoform quantiﬁcation based on SGS data. The main
reason is due to insufﬁcient length of the SGS reads. The median
length of human gene transcripts is about 2,500 bp, which is
much longer than the length of a contiguous read (about 250 bp)
currently attainable by SGS. In previous work we showed that
generally, isoform deconvolution from short-read RNA-Seq data
is not an identiﬁable problem (13), in the sense that isoform
expression cannot always be uniquely determined from the set of
exons and splice junctions. Thus, strong assumptions are made
on the set of candidate isoforms in all current methods for iso-
form assembly from short reads, including Cufﬂinks (14), SLIDE
(15), and Montebello (16); as a result, the assembled isoforms
are of uncertain accuracy. Although hundreds of RNA-Seq
datasets are being generated in any given day by diverse groups
in academia and industry, their interpretations all depend criti-
cally on the completeness and reliability of gene and isoform
annotations on the species and cell types being analyzed. Al-
though results from de novo transcript reconstruction algorithms
can provide useful hints, they are not accurate enough to stand
on their own as deﬁnitive evidence for new transcripts.
One may hope that the completeness and reliability of gene
annotation are improving commensurably with the exponential
increase in the amount and diversity of sequence data from
RNA-Seq. However, from release 43 (September 2010) to 49
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(September 2011), the number of RefSeq records for mammals
increased by 6.4% (17). Does this slow increase imply that the
annotations of mammalian transcripts are close to complete? We
believe the answer is clearly negative. The slow increase is likely
due to underinvestment in new tools and methods to generate
full-length transcript sequences. Even in well-studied species
such as human and mouse, isoforms with low to moderate
abundance are only partially sampled in full-length cDNA se-
quencing, especially when their expression is speciﬁc to a mi-
nority of cell types. Ironically, although gene annotations are
necessary for the interpretation of short-read RNA-Seq data, the
emergence of RNA-Seq itself as the preferred method to examine
the transcriptome may be contributing to a slowdown of large-scale
cDNA and EST sequencing projects that were once major sources
of experimental evidence for gene annotation. This is a funda-
mental roadblock for further progress in transcriptomic analysis.
The research reported here offers a way out of this impasse.
We address the hypothesis that full-length and large partial
fragments of transcripts can be sequenced in a massively parallel
fashion by combining SGS and third-generation sequencing
(TGS). One characteristic of TGS technologies is that they can
generate long reads. Paciﬁc Biosciences (PacBio) RS, the ﬁrst
TGS platform to offer very long reads, has an average read
length of 2–3 kb and reads of >7 kb are not uncommon (18).
Thus, the use of TGS for transcript assembly has always been
viewed as an attractive approach. In our preliminary work on this
problem, we found that the major barriers in using PacBio for
transcriptomic analysis are the relatively high error rate (up to
15%) and moderate throughput [50,000 reads per single mole-
cule real time (SMRT) cell]. To bypass the ﬁrst barrier, we de-
veloped a method to correct errors in PacBio long reads by SGS
short reads from the same transcriptome (19). Here, we address
the second barrier by proposing new statistical methods for tran-
script discovery and reconstruction based on the combined in-
formation from error-corrected long reads and short-read counts.
We applied our “hybrid sequencing” RNA-Seq method to
human embryonic stem cells (hESCs), using the well-character-
ized H1 hESC line; this line is a Tier 1 ENCODE line whose
transcriptome has been extensively studied by EST sequencing
(20) and RNA-Seq (21–23). However, even for such a well-
characterized cell line, our analysis revealed that its current an-
notation is very incomplete and there are hundreds of novel
genes/long noncoding RNAs (lncRNAs) and thousands of novel
isoforms of known genes expressed. In this paper we use the term
“novel gene/isoform” to describe a gene loci or gene isoform that
is directly detected by PacBio long reads or predicted by our
proposed method in the H1 transcriptome, and not found in
existing gene annotation databases [RefSeq, Ensembl (24),
UCSC Known Genes (25), EST (26) and GENCODE(27)]. The
lncRNAs identiﬁed by our study are on average much longer and
have more exons than those annotated in existing databases,
suggesting signiﬁcant downward bias in the current strategy for
genome-wide discovery of lncRNAs. Finally, our experimental
validation demonstrated that at least a subset of novel transcripts
represents bona ﬁde gene loci.
Results
Gene Isoform Detection and Prediction. We applied the splice
junction detection program SpliceMap (9) to 116,476,819 map-
pable 100-bp Illumina sequence reads and detected 183,825
junctions with an estimated false positive rate (FPR) of 5% (9).
Of the detected junctions, 46,898 (∼25.51%) were not reported
in RefSeq. Furthermore, many of them were found in the inter-
genic regions and formed 2,568 clusters (SI Appendix: Methods,
Short Reads Alignment and Exon Junction Detections by SpliceMap).
This suggested that existing gene annotations are incomplete and
there may exist many novel genes as well as novel isoforms of
annotated genes.
To capture multiexon transcripts, we used the PacBio RS se-
quencing platform to capture the full-length RNA in hESCs (H1
cell line). We generated full-length cDNA libraries by two dif-
ferent established methods, using polyA RNA as starting mate-
rial. The prepared double-stranded cDNA was then converted to
libraries for PacBio single-molecule real-time sequencing. In
total, 7,816,704 raw PacBio RS reads were generated. Error
correction of the raw PacBio RS reads was performed by LSC
(19). A total of 1,998,716 error-corrected long reads (GSE51861)
were mappable to the reference human genome hg19 by BLAT.
A total of 781,128 long reads covered at least one junction
supported by SpliceMap junction detection or RefSeq annota-
tion. In total, 8,084 gene transcript isoforms from RefSeq were
detected directly with a full-length read. We compared these
isoforms to the 5,851 multiexon RefSeq genes that are signiﬁ-
cantly expressed [i.e., having reads per kilobase per million
mapped reads (RPKM) >10 based on Illumina short reads] in
hESCs and found that although 61.37% of these genes are
covered by the directly detected isoforms, the detection rate
varies depending on the gene length. The detection rate is
78.18% (3,226) in the 3,689 multiexon genes of size <3,000 bp
and 32.71% (707) in the 2,162 multiexon genes of size >3,000 bp
(Fig. 1D). Although we also detected many single-exon tran-
scripts, isoform identiﬁcation of multiexon genes was of more
interest for this study and we focused on those cases. Unless
otherwise speciﬁed, the term “isoform” in the remaining text
refers to multiexon RNA isoforms.
To identify more isoforms for long genes, we developed
a statistical isoform prediction method to construct possible
isoform candidates from the union of long reads and short reads
with spliced alignment (SI Appendix: Methods, IDP—Isoform
Detection and Prediction) (http://www.stanford.edu/people/kinfai/
IDP/IDP.html). Using this method we obtained 5,459 isoform
predictions (Fig. 1A), which signiﬁcantly expanded the sensitivity
of isoform identiﬁcation beyond direct detection. We indicated
a RefSeq isoform as identiﬁed by IDP if either it was directly
detected by sequencing or there was a predicted isoform with an
identical set of exon–exon junctions. The isoform-based identi-
ﬁcation rate of signiﬁcantly expressed genes now improved to
73.70% (compared with 61.4% by direct detection). More spe-
ciﬁcally, for long genes (>3,000 bp) the identiﬁcation rate im-
proved from 32.70% to 50.23%, whereas for short genes (<3,000
bp) the identiﬁcation rate improved from 71% to 90% (Fig. 1D).
As we keep optimizing LSC and IDP, we will keep updating the
hESC transcriptome at our website (http://www.stanford.edu/
people/kinfai/IDP/hESC.html), including novel isoforms, novel
genes, novel lncRNA, and gene/isoform proﬁling.
We compared the performance of IDP isoform prediction
against Cufﬂinks, which is currently the most widely used method
for isoform identiﬁcation based on short reads [Fig. 1C; see SI
Appendix for details of receiver operating characteristic (ROC)
analysis]. At the same speciﬁcity of 5% false positive rate, IDP had
a much higher sensitivity (62% true positive) compared with
Cufﬂinks (20% true positive). This result shows that IDP is ef-
fective in using the information from the PacBio long reads to
signiﬁcantly improve isoform identiﬁcation.
The predicted (i.e., not directly detected) isoforms from IDP
included a large number of annotated isoforms that are from
RefSEq. (1,785 isoforms) or other annotation libraries [1,027
isoforms; combined Ensembl, GENCODE, and University of
California, Santa Cruz (UCSC) Known Genes]. There is also
a small group (325) of nonannotated but EST-supported iso-
forms. More importantly, 2,103 predicted isoforms are not
reported by any existing annotations. The identiﬁcation of these
isoforms provides a more comprehensive characterization of the
hESC transcriptome. As discussed below, the novel isoforms also
lead to better estimates of isoform-speciﬁc gene expression.
Novel Genes. Of the 2,103 identiﬁed novel isoforms that are not
reported by any existing annotations, 273 isoforms were tran-
scribed from 216 novel nonannotated gene loci, i.e., all of the
splicing junctions are not reported in any existing annotations
(Fig. 2A). Using the short-read data, we computed their repre-
sentation in RNA-Seq data from 16 adult human tissues (50 bp;
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Illumina Human Body Map) and their abundance ratio with
respect to H1. We began by plotting the abundance ratios of the
10 novel genes with the highest expression; 8 of these 10 genes
had <5% relative expression levels in all 16 adult tissues com-
pared with hESCs, which indicated that their expression was
highly speciﬁc to hESCs and thus they may be valuable candi-
dates for novel pluripotency markers (Fig. 2C). For example,
several long reads with up to four junctions were mapped to the
locus chr6:167,641,267–167,660,912 (hg19, the same below),
where no annotated genes in RefSeq, Ensembl, UCSC Known
Genes, or GENCODE are reported. The long reads indicated
complex expression from this locus with at least three different
isoforms transcribed (Fig. 2D). The RPKM of this gene was
31.94 in hESCs, a value much higher than the averaged RPKM
(0.53) in the other 16 adult tissues. For the other 2 novel genes
(of 10), the expression level in 16 tissues was comparable to that
of hESCs, and both of them had isoforms containing three or
more junctions. Next, to determine the hESC-speciﬁc expression
of all 216 novel genes, we calculated their abundance ratio (over
the expression in the 16 adult tissues) and we plotted it vs. the
SD of abundance ratios for each one. Sixty-eight percent of the
novel genes (146/216) had an average abundance ratio smaller
than 0.5 with SD smaller than 0.5 (inside the pink box in Fig. 2B),
which indicated that they had relative speciﬁc expression in hESCs.
Because their expression is speciﬁc to H1 hESCs, they may not
have been easily identiﬁed in the previous research. We noted
that 32% of the novel genes (70/216) were not hESC speciﬁc;
they had comparable abundance in the other human tissues.
hESC-Speciﬁc Novel Genes. To conﬁrm that the novel genes have
expression speciﬁc to hESCs, we further characterized 23 of
those showing the highest expression. For this purpose, we ex-
amined expression by quantitative PCR in two independent
hESC lines (H1 and H9), one induced pluripotent stem cell
(iPSC) line (iPSC line RiPSC.HUF1), and a collection of cDNAs
obtained from different adult human tissues. All 23 targets,
denoted as HPAT (Human Pluripotent Associated Transcript)
genes, were abundantly expressed in the pluripotent cell lines
(H1, H9, and RiPSC.HUF1) as opposed to adult tissues where
they were either undetectable or expressed at very low levels
(Fig. 3A and SI Appendix, Fig. S9A). Controls included genes
whose expression is highly enriched in pluripotent stem cells and
tissue-speciﬁc markers (SI Appendix, Fig. S9 B and C).
We also examined expression during human development, in
single blastomeres of eight-cell embryos and in human blasto-
cysts (Fig. 3B). We observed three different categories of ex-
pression: genes (HPAT1, HPAT15, and HPAT19) detected in the
blastocysts but not in the eight-cell-stage blastomeres, genes
abundantly expressed in both blastocysts and eight-cell embryos
(HPAT2 and HPAT3), and genes that were not expressed in
either stage of preimplantation development; controls were as
shown (SI Appendix, Fig. S9D). To further investigate the role of
the genes in pluripotency, we also examined their expression
during reprogramming of neonatal ﬁbroblasts toward iPSCs. We
observed that several of these genes, which were not expressed
in parental ﬁbroblasts, were activated during reprogramming
(between day 10 and day 12) with a kinetic very similar to that
observed for the pluripotency-associated genes like NANOG,
POU5F1, and DNMT3B (Fig. 3C).
To conﬁrm that the identiﬁed HPAT genes encoded functional
elements, we performed knockdown experiments. For this pur-
pose, we transfected H1 cells with siRNAs and analyzed gene
expression 24 h posttransfection. Results indicated that re-
duction of the novel hESC-speciﬁc gene (HPAT1) resulted in
signiﬁcant down-regulation of expression of several pluripotency-
associated factors including POU5F1, SOX2, NANOG, DPPA3,
DNMT3B, SALL4, and TDGF1, in a fashion similar to that ob-
served in a control sample where we down-regulated POU5F1 by
transfecting a pool of four commercially available siRNAs (Fig.
4). Other genes like LIN28A, TERT, and UTF1 were not affected
(Fig. 4), indicating a targeted effect of HPAT1 on the tran-
scriptional network of pluripotency genes. Interestingly, the
down-regulation of HPAT1 also resulted in down-regulation of
approximately half of the novel genes whereas the other half
were unaffected (SI Appendix, Fig. S10 A and B).
Novel Gene Isoforms. In addition to the novel genes, 655 identiﬁed
isoforms contained both annotated junctions and novel junctions
and thus represent novel isoforms of known genes. The novel
junctions increase the diversity of the existing known isoforms. A
total of 758 novel junctions from this subgroup of isoforms were
categorized by type (Fig. 5A). Twenty-four percent and 25% of
the novel junctions resulted from novel splice sites at the 5′ end
and the 3′ end, respectively. Seven percent of the junctions
accounted for intron retention events. Fifteen percent resulted
from exon-skipping events. Nine novel junctions were deﬁned
“intergenic proximal” because they fell upstream or downstream
Fig. 1. Gene isoform detection and prediction of
hESCs (H1 cell line) by IDP. (A) Venn diagram of IDP
detections and predictions (see introductory section
for deﬁnition of detection and prediction). A total
of 8,084 RefSeq isoforms are detected and high-
lighted in blue. A total of 10,811 predictions are
highlighted in yellow and outlined with a thick
black line. A total of 5,352 detections of RefSeq
isoforms are also predicted by IDP. (B). Pie chart of
annotated isoforms and novel isoforms in IDP pre-
dictions. IDP predictions rescue 1,785 RefSeq-anno-
tated isoforms (in purple) that cannot be detected
directly at full length. In addition, there are 1,027
predictions that are not annotated in RefSeq but
are found in Ensembl, Known Genes, or GENCODE
(cyan). Finally, 2,428 novel isoforms (green and red)
are identiﬁed, 325 of which have EST support (red).
(C) ROC performance analysis of IDP and Cufﬂinks.
IDP predictions have much higher sensitivity in the
acceptable FPR range from 5% to 10%. When FPR is
controlled to 5%, the IDP prediction sensitivity is as
high as ∼62%, whereas the corresponding Cufﬂinks
sensitivity is only about 20%. (D) RefSeq gene
identiﬁcation rate decreases with the gene length.
Combining detections and predictions, the overall identiﬁcation rate by IDP is ∼73% (yellow line with blue star markers). IDP prediction rescues
a signiﬁcant number of isoforms from long genes that are not directly detected.


















of the annotated genes, thus extending the gene locus with novel
exons and novel isoforms (Fig. 6). None of these novel splices
have been reported in previous annotations.
Without any novel junctions, novel combinations of annotated
junctions can generate novel isoforms as well. A total of 876 novel
isoforms are identiﬁed in this category. This ﬁnding indicates that
the completeness of junction libraries does not guarantee the
completeness of gene isoform identiﬁcation. Although SGS data
have shown impressive performance in junction detection at local
regions, new techniques such as IDP from hybrid-sequencing data
are needed in isoform identiﬁcations.
Compared with annotated isoforms, the expression levels of
the novel genes and novel isoforms identiﬁed by IDP are lower
overall (Fig. 5B). However, a signiﬁcant proportion (35.58%) have
reasonably high expression levels (RPKM >10). Thus, previous
approaches have yielded incomplete annotations even for highly
expressed genes. IDP will be useful in ﬁlling this gap.
Quantiﬁcation of Isoform Abundance. Estimates of isoform-speciﬁc
gene expression from high-throughput SGS data rely on statis-
tical models in which a short read that is consistent with two or
more of the annotated isoforms is regarded as being more likely
to be generated from the more abundant isoforms (12). Isoform
abundance estimates based on these models are highly sensitive
to the annotation. Two types of isoform annotation libraries are
often used: (i) reference annotation libraries such as RefSeq or
Ensembl or (ii) candidate isoform sets inferred computationally
by SGS analysis tools such as Cufﬂinks and SLIDE. Because
a reference annotation library is constructed based on all data
from the same species, not all annotated isoforms in the library
are truly expressed in a sample. The inclusion of annotated but
not truly expressed isoforms can greatly increase the variability
of the abundance estimates of the expressed isoforms—as dis-
cussed in section 4.2 of ref. 12, this shows up as a widening of the
95% interval for an isoform’s abundance when additional iso-
forms are included in the model. On the other hand, if the ref-
erence library is incomplete, then any nonannotated but truly
expressed isoforms are completely missed and their contribution
to short-read coverage may be incorrectly assigned to the an-
notated isoforms. These two effects can lead to serious errors in
the abundance estimates based on a reference library. Finally,
for multiexon genes there are usually many isoforms consistent
with the exon and junction reads from SGS data. As a result,
candidate isoform sets inferred directly from the SGS data may
include many false isoforms that cause incorrect abundance es-
timation. In contrast, in our approach the error-corrected long
reads are ideal for narrowing down the isoforms expressed in
a sample, thus enabling much more reliable abundance quanti-
ﬁcation from SGS reads.
To evaluate the bias in quantiﬁcation due to incomplete an-
notation, we computed the isoform expression levels from SGS
short reads based on two different isoform libraries: RefSeq
annotation and IDP isoform identiﬁcation from hESC data (Fig.
7). There are 9,775 isoforms appearing in both libraries (com-
mon isoforms). Of these, 1,763 are from genes with at least one
novel isoform (group 1, with novel isoforms) and 8,012 are from
genes without any novel isoform discoveries (group 2, without
novel isoforms). For genes in group 2, the expression of a com-
mon isoform, computed via the RefSeq library, is well correlated
with that computed based on the IDP library (R2 = 0.9985). In
contrast, for group 1 genes this correlation is much lower (R2 =
Fig. 2. Novel gene identiﬁcations. (A) A total of 2,428 novel isoforms are categorized according to the use of the annotated junctions. A total of 273 isoforms
from 216 novel genes are observed (in brown). A total of 655 novel isoforms use at least one junction from annotated genes (in orange). A total of 876 novel
isoforms are novel combinations of annotated junctions. Six hundred twenty-four are fragments of annotated isoforms. (B) Differential expression of 216
novel genes in H1. The abundance ratio of a novel gene in a given tissue is deﬁned as its abundance in this tissue divided by its abundance in H1. One hundred
forty-six novel genes (68%, inside the pink box) have an averaged abundance (among 16 human tissues) ratio smaller than 0.5 with SD smaller than 0.5. (C)
Relative expression levels of the top 10 novel genes (10 highest expressions in hESCs) in 16 human tissues. The reference expression levels are expressions in
hESCs (highlighted in red line with triangles). Eight novel genes have high expression speciﬁcally in hESCs (example 8 in D) whereas the other 2 have sig-
niﬁcant expression across many different tissues. The gene structure of the eighth novel gene is visualized in D. (D) Novel gene at chr6:167,641,267–
167,660,912. The dark green track shows the nonredundant long reads, each of which represents an alignment. The arrow refers to the alignment of the read
relative to the reference (i.e., aligned to reference or to reverse complement of reference) and is not the direction of transcription. The naming of non-
redundant long reads is A_Bjccs ± D, where A is the percentage identity of BLAT alignment, B is the length of alignment, and D is the distance between the
mappable part of the long read and the polyA/polyT detection (“+” is the forward strand and downstream whereas “−” is the reverse strand and upstream).
PacBio circular consensus sequence (CCS) reads are labeled with “ccs”. The orange track shows IDP predictions. The 35-bp mappability of this locus is in black.
The light green track is GENCODE annotation and the brown one is Ensembl. RefSeq (light purple track) and UCSC Genes are also displayed but they have
no annotated genes in this locus and thus no IDP detections (referenced to RefSeq, red track) are displayed either. The track display settings of other ﬁgures
are the same.
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0.6008). Therefore, novel gene isoform discoveries have impor-
tant effects in the accuracy of abundance estimations.
The linear regression of all 9,775 common isoforms shows the
difference of abundance correction between group 1 and group 2
(Fig. 7). IDP-sample-speciﬁc estimations in group 1 genes tend to
have lower RPKM because some SGS short reads must now be
shared with the novel isoforms. This conﬁrms that novel isoform
identiﬁcations have a signiﬁcant impact on the isoform abundance
estimation within a gene. Therefore, our sample-speciﬁc IDP
pipeline also leads to a more reliable isoform-speciﬁc expres-
sion estimation that will beneﬁt downstream analyses.
Use of Gene Isoforms and Exon Junctions.Although there are ∼20,000
multiexon genes with 35,000 ∼ 40,000 isoforms in RefSeq, the
total number of isoforms identiﬁed in hESCs is only 13,292. A
total of 12,976 isoforms (RefSeq annotated or unannotated)
were identiﬁed from 4,312 genes of 5,851 RefSeq multiexon
genes with RPKM >10. The identiﬁcation rate is 73.70% among
these RefSeq genes (Gene Isoform Detection and Prediction). A
total of 91.18% express only one or two dominantly expressed
isoforms in hESCs (Fig. 8). Gene functions within a cell may
depend only on a subset of possible isoforms. Thus, there must
exist sophisticated transcriptional and posttranscriptional regula-
tory mechanisms to select and express a correct subset of isoforms
in certain cell conditions. On the other hand, some genes express
many isoforms in hESCs, such as 14 isoforms from the ncRNA
gene NCRNA00188 and 13 from mortality factor MORF4L2.
In contrast to limited use of isoforms, the number of junctions
used within a gene has a much larger range from 1 to 50. Thus,
the IDP pipeline with hybrid sequencing data has identiﬁcation
power not only in simple genes but also in the complex genes
with many alternative splices, such as the 49-junction gene
RBM5 (RNA-binding protein 5) and the 50-junction gene DPP4
(adenosine deaminase complexing protein). This advantage of
obtaining global gene structure with so many junctions is due to
the TGS long reads and is not achievable by SGS short reads. In
addition, the median number of junctions within a gene identi-
ﬁed by IDP is 7, which is the same as in RefSeq annotation.
It is interesting to note, however, that the number of junctions
within a gene has no signiﬁcant correlation with the number of
expressed isoforms (Fig. 8). This suggests that the number of
expressed isoforms is largely determined by the need of the cell
and does not depend on the complexity of the gene junctions.
Isoforms of Pluripotent Stem Cell Markers. Many genes are ex-
pressed with great speciﬁcity in hESCs. Reliable and sensitive gene
isoform identiﬁcation enables improved observation of the use of
isoforms in hESCs. Here we report isoforms from 15 pluripotent
stem cell markers (Table 1). As with most genes, these markers
have signiﬁcant expression of only one to two annotated isoforms,
most of which can be detected directly by error-corrected full-length
cDNA reads. Two annotated isoforms KLF4 and E-cadherin are
the exceptions and are predicted by IDP.
The transcriptional regulator of pluripotency, POU5F1, ex-
presses two isoforms, which are distinct from the RefSeq-annotated
Fig. 3. Gene expression validation of HPAT. (A) Gene ex-
pression analysis by qPCR was performed on two hESC
samples (H1 and H9), one iPSC line (RIPSC.HUF1), and
a collection of cDNAs from fetal and adult tissues. (B) Gene
expression proﬁling of HPAT genes in single blastomeres of
eight-cell embryos and blastocysts. E1 and E2 denote the
embryos from which blastomeres were isolated. (C) Reac-
tivation of genes during the reprogramming process. Cells
were analyzed at different time points of mRNA-mediated
iPSCs derivation.


















isoform NM_001173531. In addition, a few long reads are ob-
served that exhibit intron retentions within two detected isoforms
(NM_203289 and NM_002701). However, the corresponding
intronic coverage is not high, so these intron retention events
may be from preprocessed transcripts. Similar intron reten-
tion events with low expression also exist in NANOG, TERT,
and DNMT3B.
Compared with intron retentions that occur at low frequency,
novel isoforms with highly expressed exon-skipping events are
more interesting. For example, in the DPPA4 locus, a RefSeq-
annotated isoform is expressed but a novel isoform skipping
three exons contributes ∼17% of the total gene abundance (SI
Appendix, Fig. S11A). In TERT, a novel isoform displaying cas-
sette exon skipping junctions contributes as much as 54% of the
gene abundance. Alternative splicing may be one mechanism of
regulation of the telomerase activity of TERT.
As a third example, we note that a novel exon (not in RefSeq)
is observed in SALL4. Although this exon was reported in an
isoform of SALL4 in Ensembl, the Ensembl-annotated isoform is
a partial fragment of the IDP-predicted isoform (SI Appendix,
Fig. S11B).
ncRNA Identiﬁcation. In addition to genes coding for proteins, 480
annotated (RefSeq) multiexon ncRNAs were identiﬁed from
IDP, 85% (406/480) of which are direct detections. The
remaining 3,455 non–RefSeq-annotated IDP multiexon isoform
predictions (green plus red plus light blue fractions in Fig. 1B:
2,103 + 325 + 1,027 = 3,455) are compared with the GEN-
CODE lncRNA library (V12), which was created through man-
ual curation of available cDNA and EST data. A total of 116 are
found within this lncRNA library (Fig. 9A). In addition to
RefSeq and GENCODE ncRNAs, the remaining IDP isoforms
were compared with the Human Body Map (HBM) long inter-
genic noncoding RNA (lincRNA) library, which uniﬁes existing
annotation sources with transcripts assembled from SGS RNA-
Seq data collected across 24 tissues and cell types (28). Forty-six
are found from this lincRNA library. To further study the
remaining predictions, two functional RNA structure prediction
tools, RNAz (29, 30) and alifoldz (31), were applied to predict
the secondary structure potential of the novel ncRNAs remain-
ing in the IDP output. Previous research had suggested the use of
two stringency levels for predictions from two methods (32) (Fig.
9B and SI Appendix,Methods). To have a more conﬁdent ncRNA
library for hESC study, we used a high-stringency mode for each
method [P ≥ 0.9 for RNAz; minimum free energy (MFE) ≤ −15
and Z score ≤ −4 for alifoldz]. We then took the intersection of
the two sets of predictions. In total, 111 IDP novel isoforms (P
value for overlap <0.0001) are predicted as structured ncRNAs
by both methods. We also computed their abundance ratio in 16
human tissues with respect to H1. The abundance ratios of 104
novel ncRNAs from all 16 human tissues with respect to (w.r.t.)
H1 can be computed, whereas 7 targets have insufﬁcient short-
read coverage in H1. A total of 48.08% (50/104) of novel
ncRNAs have an averaged abundance ratio smaller than 0.5 with
SD smaller than 0.5 (pink box in Fig. 9C), which indicates that
these genes tend to have relatively higher expression in H1.
GENCODE lncRNAs and HBM lincRNAs found in hESCs
have very different length distributions compared with ncRNAs
predicted by our method or found in RefSeq annotations (Fig.
9D). Only 4 of the GENCODE lncRNAs (3.4%) and 1 HBM
lincRNA (2.2%) are longer than 2,000 bp, whereas 216 RefSeq-
annotated (45%) IDP isoforms and 72 predictions (65%) from
novel IDP isoforms are longer than 2,000 bp with the averaged
lengths around 2,300 bp (Table 2). Furthermore, the isoforms
from the latter two IDP groups have more junctions: 183 (38%)
RefSeq-annotated IDP hits and 187 predictions (70%) from
novel IDP hits have more than 4 junctions (that is, at least 6
exons), whereas only 6 of GENCODE lncRNAs and none of the
HBM lincRNAs have more than 4 junctions (Fig. 9E). The av-
erage number of junctions is 1.72 in the HBM lincRNA group
and 1.91 in GENCODE lncRNAs, which is far smaller than 4.52
and 7.67 in the RefSeq group and IDP novel ncRNAs.
Isoforms in HBM lincRNA and GENCODE lncRNA librar-
ies, regardless of tissue type, are generally much shorter and
contain fewer junctions compared with those identiﬁed by IDP in
hESCs (Fig. 9 D and E). However, such striking differences are
not seen in the abundance distribution (Fig. 9F). These results
suggest that SGS data and manual curation of cDNA and EST
data are likely to underestimate the size and complexity of
ncRNA isoforms. By combining SGS and TGS data, our approach
can provide a much more accurate characterization of ncRNAs.
Finally, a signiﬁcant percentage (27.93%, 31 of 111) of the novel
Fig. 4. Functional effect of down-regulation of HPAT genes. Gene expres-
sion analysis by qPCR of different pluripotency-associated genes after down-
regulation of GFP (negative control, in green), OCT4 (positive control, in
yellow), and HPAT1 (in red). siRNAs for GFP and HPAT1 were derived by in
vitro dicer-mediated digestion of the corresponding double-stranded mRNAs;
siRNAs for OCT4 were designed in silico. Analysis was performed 24 h after
the transfection.
Fig. 5. Novel isoform identiﬁcations. (A) Pie chart of different novel junc-
tion types in 655 novel isoforms of existing genes. N5U, novel 5′-UTR; N3U,
novel 3′-UTR; N5S, novel 5′-splice site; N3S, novel 3′-splice site; IR, intron
retention; ES, exon skipping; InterG, intergenic proximal. Examples are in
Fig. 6. (B) Abundance distributions of novel isoform predictions and anno-
tated detections. Approximately 35% novel isoforms have RPKM >10.
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IDP lncRNA isoforms predicted by our method are highly
expressed (RPKM >10, Fig. 9F). Further investigation of this set
of novel, long, and highly expressed ncRNAs will be worthwhile.
Discussion
We have identiﬁed de novo isoform discovery and assembly as
a fundamental obstacle to progress in RNA-Seq analysis. Inno-
vations on both the conceptual level and the technical level are
presented to overcome this obstacle. On the conceptual level, we
distinguish two different types of RNA-Seq analysis and argue
that it is desirable to develop different experimental and com-
putational approaches for them separately. In discovery, analysis
aims to identify all genes and gene isoforms that are being
transcribed in a particular cell sample. Once it is done well for
a particular species and cell type, it will contribute to the im-
provement of gene annotation for that species and will beneﬁt all
subsequent RNA analysis on that species. For quantiﬁcation, on
the other hand, analysis aims to estimate expression (preferably
also allele-speciﬁc) levels of the gene isoforms in an annotation
that speciﬁes the set of isoforms actually present. It is anticipated
that quantiﬁcation analysis will be performed on a very large num-
ber of samples in translational research and in clinical applications.
In these contexts it is very important to have high throughput
and low cost.
A large amount of statistical and computational research has
been performed over the past 5 y on how to analyze short-read
RNA-Seq data for both types of analyses. It appears that many
effective methods for quantiﬁcation are now readily available.
Most of these methods have incorporated variations of the con-
cepts of RPKM from the Wold laboratory (1) as an expression
Fig. 6. Novel isoforms of existing genes with six different types of novel junctions. The genome browser setting is the same as in Fig. 2D. The GENCODE
annotation is in the dark blue track. The novel junction uses are highlighted by a pink dashed box and are not reported by existing annotations but are
supported by both long reads and short reads. Other: a novel exon in novel isoform TMEM142.2 is detected with two novel ﬂanking junctions that are
categorized in the “Other” group in Fig. 2C. InterG: A novel junction in novel isoform INO80C.1 is categorized as “intergenic proximal” junctions from
annotated genes, but is a 3′-end junction of a novel isoform of INO80C (note that this gene is in the reverse strand). IR: A novel junction in novel isoform
YTHDF1.1 indicates a splice within an annotated exon; i.e., the RefSeq annotation has a retained intron relative to YTHDF1.1. N3S: A novel junction in novel
isoform MBD1.1 has a novel 3′-splice site (note that this gene is in the reverse strand). N5S: A novel junction in novel isoform TTC32.1 has a novel 5′-splice site
(note that this gene is in the reverse strand). ES: Novel isoform HSD17B14.1 contains a novel junction that skips an annotated exon.


















index and the Poisson deconvolution model (12) as the statistical
framework for isoform-level inference. As for discovery, several
algorithms, such as Tophat, SpliceMap, and MapSplice, have been
developed to map splice junctions with high sensitivity and spec-
iﬁcity. Based on the detected junctions and short-read counts,
several methods such as Cufﬂinks and SLIDE have also been
proposed to assemble the set of expressed isoforms. Our belief is
that although these methods can provide useful information, the
assembly problem cannot be solved effectively based on short-
read RNA-Seq data alone. Instead, we pursued a hybrid TGS-
SGS sequencing approach that at this moment is more costly
than SGS alone. However, the decoupling of the task of dis-
covery from quantiﬁcation allowed us to conclude that even with
its higher cost, hybrid sequencing is an attractive approach for
discovery, as the cost will be offset by the gained accuracy in all
subsequent quantiﬁcation analysis due to the resulting improve-
ment of annotation.
On a technical level, we have developed an analysis method-
ology to combine the speciﬁc strengths of TGS and SGS, rep-
resented by PacBio and Illumina sequencing, respectively. Our
methodology involves new statistical modeling and inference.
Although the error-corrected long reads are capable of capturing
many transcripts in full length, there will always be a substantial
fraction of long reads that capture only partial transcript frag-
ments. This is particularly likely if the transcript is very long. It is
important to be able to combine the information from the full-
length long reads and partial transcript fragment reads. Fur-
thermore, there is also statistical information useful for isoform
reconstruction, and this information can be substantial because
the number of short reads will be an order of magnitude larger
than the number of long reads. To effectively use all three types
of reads for isoform reconstruction, we developed statistical
models for how such reads are sampled from the underlying
isoforms and derive appropriate algorithms to infer the isoforms
based on such models. To our knowledge, such models are not
available currently, and the development of these represents
signiﬁcant innovation in statistical methodology.
Finally, to test our method, we generated 2 million mappable
long reads on H1 hESCs and analyzed them in conjunction with
existing short-read RNA-Seq data. Our analysis not only illus-
trates the effectiveness of our method, but also provides a rich
resource for stem cell biologists interested in a deeper charac-
terization of the ESC transcriptome. Indeed, further character-
ization of the novel loci identiﬁed here indicates that a subset is
speciﬁcally and highly expressed in pluripotent human stem cells
and embryos. Moreover, silencing of these genes modulates plu-
ripotency gene expression. Thus, at least a subset of these gene
loci may have functional roles in both human development and
pluripotent stem cells. Taken together, these results demonstrated
the effectiveness of our methodology and suggest that gene iden-
tiﬁcation, even in well-characterized cell lines and tissues, is far
from complete.
Experimental Procedures
Cell Culture. Male human embryonic stem cells (H1) were used for our study.
The cells were routinely cultured in feeder-free conditions on Matrigel (BD)
and in mTeSR1 (Stem Cell Technologies). RNA-Seq was performed on cells
between passages 50 and 55. The undifferentiated state of the hESCs was
assayed by immunoﬂuorescence for transcription factors OCT4 and NANOG
Fig. 7. Isoform abundance estimation by IDP-identiﬁed hESC transcriptome
and RefSeq annotation. The gene abundances of “common isoforms” (main
text) are rescaled by a square-root transformation. The genes without novel
isoforms (group 2) have stable abundance estimation and have high R2 of
0.9985 in linear regression (blue dots). In contrast, novel isoforms found in
existing genes lead to a large range of abundance corrections. The residuals
of linear regression show different distributions between the two groups.
Group 1 (genes with novel isoforms) is highlighted in orange and group 2 in
blue. The residuals of group 2 concentrate around 0, which indicates a small
difference between two computations. However, group 1 has a heavy tail at
the positive range. That is, most abundances of group 1 are corrected to
lower values because the SGS reads must be shared with novel isoforms.
Fig. 8. (A) Marginal distributions of numbers of
junction use. (B) Marginal distributions of numbers
of isoform use. (C) Joint distribution displayed as
heat map of number of genes by number of junc-
tions and number of isoforms. The numbers of
genes are given in each bin. Most genes express
only one to two isoforms. Note that the number of
junctions and the number of expressed isoforms
within a gene have no signiﬁcant correlation.
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and for the surface markers SSEA4, TRA-1-60, and TRA-1-81 (SI Appendix,
Fig. S12). Pluripotency, assessed by teratoma assay, revealed the capacity of
hESCs to form in vivo derivatives of the three germ layers (SI Appendix,
Fig. S13).
RNA and cDNA Preparation. Total RNA was prepared by TRIzol extraction
(Ambion; www.ncbi.nlm.nih.gov/pubmed/2440339) and treated with RNase-
free DNase I to degrade contaminating genomic DNA. This was followed by
a second extraction with acid-phenol-chloroform and the RNA was pre-















DNMT3B Novel isoforms are identiﬁed with intron retention events
ZFP42 NM_174900 A novel isoform has an alternative splicing site at the last exon
SALL4 NM_020436 A novel isoform (with 20% gene abundance) contains a novel exon
DPPA4 NM_018189 A novel isoform skips three exons
TERT A novel isoform skips exon 7 and exon 8 and the exon-skipping junction is of high expression
Fig. 9. Noncoding RNA identiﬁcation: the distributions of length, number of junctions, and abundance. (A) Annotated ncRNA identiﬁcations and novel
ncRNA predictions. A total of 480 multiexon RefSeq-annotated ncRNAs are identiﬁed from H1. After ﬁltering out RefSeq isoforms, the remaining IDP output
contains 116 GENCODE-annotated lncRNAs. After ﬁltering out RefSeq and GENCODE isoforms, 46 HBM lincRNAs are identiﬁed. The intersection of high-
signiﬁcance RNAz and alifoldz predictions of the remaining novel isoforms contains 111 putative ncRNAs. (B) RNAz and alifoldz are used to identify the
ncRNA from 2,428 isoform predictions. Two stringency levels are suggested by the developers. For all subsequent analyses, we use the intersection of the
high-stringency outputs from the two methods as our predicted ncRNAs. (C) Differential expressions of 104 novel ncRNAs w.r.t. H1. Seven of 111 novel ncRNA
predictions are not included, because of insufﬁcient short-read coverage in H1. Fifty novel ncRNAs (inside the pink box) have an averaged abundance ratio
smaller than 0.5 with SD smaller than 0.5. (D) Length distribution of IDP-identiﬁed isoforms of RefSeq ncRNA, GENCODE lncRNA, HBM lincRNA, and RNAz/
alifoldz predictions. (E) Distribution of number of junctions of IDP-identiﬁed isoforms of RefSeq ncRNA, GENCODE lncRNA, HBM lincRNA, and RNAz/alifoldz
predictions. (F) Abundance distribution of IDP-identiﬁed isoforms of RefSeq ncRNA, GENCODE lncRNA, HBM lincRNA, and RNAz/alifoldz predictions.


















cipitated in 0.5 M ammonium acetate and 2.5 vol ethanol. The integrity of
the RNA was tested by a Bioanalyzer RNA Nano assay (Agilent). PolyA RNA
was puriﬁed from the total RNA (>100 μg), using magnetic oligo-dT beads
(Dynal) according to the manufacturer’s recommended protocol.
Two different manufacturer’s kits and accompanying protocols for gen-
erating full-length cDNAs were used: Clontech SMARTer PCR and the Invi-
trogen SuperScript Full-Length cDNA kit. Each uses a retroviral reverse
transcriptase to initiate cDNA synthesis at the 3′ polyA tail, but the two kits
use different mechanisms to capture the 5′-end information. The Clontech
method relies upon template switching to an exogenous tag oligonucleotide
when the reverse transcriptase reaches the 5′ end of the molecule. The
Invitrogen method employs an RNase I digestion and subsequent 7-methyl-
guanosine afﬁnity step to purify the RNA-DNA hybrids that represent a full
copy of the transcript. This is followed by a DNA ligase step to add a deﬁned
sequence to the 3′ ends of the full-length cDNA, before reverse transcrip-
tion. For each method, 1 μg of polyA RNA served as the input material into
the recommended protocol and the manufacturers’ methods were followed
up through second-strand cDNA synthesis. At this point, PCR (12–15 cycles;
Phusion DNA polymerase; New England Biolabs) was used to amplify the
double-stranded cDNA by using speciﬁc primers directed to the deﬁned
sequences present at the 5′ and 3′ ends of the cDNAs. Long extension times
of 3.5 min ensure that longer molecules can be captured as well. The cDNA
libraries were assayed by ﬂuorimetry and Bioanalyzer assays. Both Clontech
and Invitrogen kits are reproducible. For example, housekeeping genes at
different sizes (ACTB, 1,808 bp; GADPH, 1,310 bp; SARS, 2 291 bp; and IARS,
NM_002161, 4,406 bp and NM_013417, 4,510 bp) are detected by full-length
long reads from the two preparations (SI Appendix, Figs. S14–S17).
Size selection was used with each of the cDNA libraries to enrich for larger
cDNA molecules. Brieﬂy, 500 ng of double-stranded cDNA was separated on
a 1× TAE agarose gel and stained with SybrSafe. The gel was visualized on
blue light to avoid DNA damage and, using a size standard in a parallel lane,
size fractions were cut from the gel from 1 kb to 2 kb, from 2 kb to 3 kb, and
from 3 kb to 10 kb. The DNA was recovered from each fraction, using a silica
column kit (Zymo), and the DNA was then subjected to additional PCR to
enrich for molecules in each size fraction. For both non–size-selected and
size-selected PCR reactions, the double-stranded cDNA was puriﬁed via
AMPure PB beads (Paciﬁc Biosciences), using a 0.5× ratio of bead slurry
to PCR.
Single-Molecule Sequencing. Sequencing templates were prepared using the
manufacturer’s SMRTbell template protocol (Paciﬁc Biosciences Large Tem-
plate Prep kit), with a minimum of 1 μg of dsDNA input into each library
procedure. After exonuclease digestion of incomplete SMRTbell templates,
the libraries were puriﬁed by three sequential 0.5× AMPure PB puriﬁcations
(Paciﬁc Biosciences.) Libraries were quantiﬁed by ﬂuorimetry and assayed
for quantity and size distribution by Bioanalyzer. Sequencing was performed
on the Paciﬁc Biosciences RS, using standard protocols for C2 chemistry with
the C2 or XL enzyme.
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